This strategy seems promising since PCa cells express different prostate-specific antigens, such as prostatic acid phosphatase (PAP), prostate-specific membrane antigens (PSMA) and prostate-specific antigens (PSA) [97]. The gene discussed is ACP3; the disease is posterior cortical atrophy.